Fundz

Dragonfly Endoscopy Inc. reported raising $12.7 Million in an initial SEC Form D filing, from an offering of $12.7 Million

PRIVATEMar 11, 2022

Amount Raised

$12.7 Million

$12.7 Million sold, per SEC Form D (first sale Mar 11, 2022)

Round Type

Venture

WalthamHealthcare

Quick answer

Dragonfly Therapeutics, Inc. raised $12.7 Million in a funding round, dated March 11, 2022. Dragonfly Therapeutics, Inc. is based in Waltham, Massachusetts, United States.

How much did Dragonfly Therapeutics, Inc. raise?
Dragonfly Therapeutics, Inc. raised $12.7 Million in a funding round on March 11, 2022.
What does Dragonfly Therapeutics, Inc. do?
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel technology to harness the body's immune system to bring..
Where is Dragonfly Therapeutics, Inc. based and how big is it?
Dragonfly Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
Who are the decision-makers at Dragonfly Therapeutics, Inc?
Fundz holds 1 contact at Dragonfly Therapeutics, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Dragonfly Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Jaguar Health raised $8K on April 25, 2022.
  • EarLens Corp raised $6M on April 25, 2022.
  • Oral Genome raised $13K (Pre-Seed) on April 25, 2022.
  • Jaguar Health raised $40K on April 25, 2022.
  • Third Eye Health, Inc. raised $4M (Seed) on April 25, 2022.
  • COPE Healthcare Consulting, Inc. raised $7.5M on April 22, 2022.

Who to call at Dragonfly Therapeutics, Inc., and when

A new round usually means Dragonfly Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Dragonfly Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dragonfly Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dragonfly Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dragonfly Therapeutics, Inc.

Location

9800 PYRAMID COURT

Waltham, Massachusetts, United States

About

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel technology to harness the body's immune system to bring breakthrough treatments to patients. Dragonfly has a deep pipeline of wholly-owned clinical and preclinical candidates discovered using its proprietary platform that are progressing toward the clinic, as well as productive collaborations with Bristol Myers Squibb, Merck and AbbVie across a broad range of disease areas. For more information visit us at www.Dragonflytx.com, or follow us on Linkedln and Twitter.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dragonfly Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Dragonfly Therapeutics, Inc.'s next move

See what Strategic adds

Dragonfly Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.